- Professor, Division of Pediatric Endocrinology
- Division Chief of Pediatric Endocrinology and Diabetes
- Department of Pediatrics, Medical School
Antoinette Moran, MD, strives every day to make a difference in the lives of her patients with type 1 diabetes and cystic fibrosis related diabetes (CFRD). Moran is division chief of Pediatric Endocrinology and Diabetes at the University of Minnesota and she has been taking care of patients with diabetes since 1987. Her research in CFRD resulted in her being named the first annual recipient of the Cystic Fibrosis Foundation’s Richard C. Talamo Distinguished Clinical Achievement Award, for “research contributions that have had significant influence on the course of the disease.” She recently co-chaired a national consensus conference on guidelines for the management of CFRD, sponsored by the Cystic Fibrosis Foundation, the American Diabetes Association and the Pediatric Endocrine Society. Moran is currently studying the prevention and cure of type 1 diabetes as part of TrialNet and the Immune Tolerance Network. For the last 6 years she has been helping to develop pediatric diabetes programs in East Africa.
- Professor, Division of Epidemiology and Community Health, School of Public Health
Mark Pereira, PhD, is a professor of Epidemiology and Community Health in the School of Public Health. Pereira’s current research interests include the role of dietary composition, as well as eating and physical activity patterns in the etiology, prevention, and treatment of type 2 diabetes and cardiovascular disease throughout the lifespan. Pereira is available to discuss topics regarding diet or physical activity related to chronic diseases, including type 2 diabetes, obesity and cardiovascular diseases, sugar and artificially sweetened beverages, related policies and taxation, and his recent research involving sit-stand workstations to reduce sedentary time and improve health in office workers.
- Professor of Medicine, Division of Endocrinology and Diabetes
- Pennock Family Chair in Diabetes Research
Elizabeth Seaquist, MD, is a diabetes expert whose ultimate goal is to improve the lives of people with diabetes. Seaquist’s research interests looks at the effects of diabetes on brain metabolism, structure and function. She is currently heading projects to learn how the brain adapts to diabetes and recurrent hypoglycemia with the long term goal of developing new therapies for the disease. She also leads the NIH funded ACCORDION (Action to control cardiovascular risk in diabetes follow on study), the Eli Lilly funded Researching Cardiovascular Events with a Weekly Incretin in Diabetes (REWIND) study, and is principal investigator on the NIH funded T32 training grant in diabetes, endocrinology, and metabolism. Currently, Seaquist is leading the University of Minnesota site for glycemia reduction approaches in diabetes (GRADE), which are NIH and clinically funded trials focused on identifying the best treatments for patients with type 2 diabetes.
- Associate Professor, Pharmaceutical Care & Health Systems
- Director, Ambulatory Care Residency Program, College of Pharmacy
As a pharmacist, associate professor and director of the U of M College of Pharmacy’s pharmacist residency program, Sarah Westberg is well versed in pharmacist-patient interactions. During medication management appointments, she meets with patients one-on-one to review current medications, adjusts dosages and identifies conflicting or unhelpful medicines. Her pharmacy expertise uniquely qualifies her to improve patient health through medication optimization. Westberg is available to discuss this patient-centered pharmaceutical care, especially in the context of diabetes or women’s health.